Company profile for Acesion Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Our technology is based on research initiated in 2008 at University of Copenhagen and chemistry insights from the company Neurosearch. Acesion Pharma aims to develop more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. Existing drug therapies generally have a limited eff...
Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Our technology is based on research initiated in 2008 at University of Copenhagen and chemistry insights from the company Neurosearch. Acesion Pharma aims to develop more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. Existing drug therapies generally have a limited effect or are associated with risk of serious adverse events, and there is a considerable patient need for developing better and safer drugs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Denmark
Address
Address
Ole Maaløes Vej 3 2200 Copenhagen
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/acesion-pharma-announces-nature-medicine-publication-of-clinical-results-in-atrial-fibrillation-302013119.html

PR NEWSWIRE
13 Dec 2023

https://www.prnewswire.com/news-releases/acesion-pharma-closes-oversubscribed-45m-series-b-financing-round-to-advance-development-of-novel-therapy-for-atrial-fibrillation-301938312.html

PR NEWSWIRE
26 Sep 2023

https://www.prnewswire.com/news-releases/acesion-pharma-announces-positive-pre-clinical-data-for-ap31969-301823594.html

PR NEWSWIRE
15 May 2023

https://www.clinicaltrialsarena.com/news/acesion-pre-clinical-af-therapy/

CLINICAL TRIALS ARENA
15 May 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty